Connor, Clark & Lunn Investment Management Ltd. Adverum Biotechnologies, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.68 - $1.59 $44,593 - $104,269	-65,578 Reduced 43.76%	84,278 $134,000
Q1 2023 May 09, 2023	SELL	$0.62 - $0.85 $31,392 - $43,038	-50,633 Reduced 25.25%	149,856 $107,000
Q4 2022 Feb 10, 2023	SELL	$0.54 - $10.3 $1,747 - $33,330	-3,236 Reduced 1.59%	200,489 $116,000
Q3 2022 Nov 10, 2022	BUY	$0.96 - $9.68 $82,764 - $834,541	86,213 Added 73.37%	203,725 $194,000
Q2 2022 Aug 05, 2022	SELL	$0.81 - $1.34 $150,016 - $248,174	-185,205 Reduced 61.18%	117,512 $141,000
Q1 2022 May 12, 2022	SELL	$1.23 - $1.95 $44,308 - $70,244	-36,023 Reduced 10.63%	302,717 $397,000
Q4 2021 Feb 10, 2022	SELL	$1.74 - $2.4 $51,617 - $71,196	-29,665 Reduced 8.05%	338,740 $596,000
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $766,282 - $1.33 Million	368,405 New	368,405 $799,000
Q2 2019 Aug 07, 2019	SELL	$5.1 - $11.89 $367,327 - $856,377	-72,025 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$3.03 - $6.02 $49,389 - $98,126	-16,300 Reduced 18.45%	72,025 $377,000
Q4 2018 Feb 12, 2019	SELL	$2.87 - $5.92 $196,092 - $404,484	-68,325 Reduced 43.62%	88,325 $278,000
Q3 2018 Nov 13, 2018	SELL	$4.5 - $7.6 $22,500 - $38,000	-5,000 Reduced 3.09%	156,650 $948,000
Q2 2018 Aug 02, 2018	SELL	$5.3 - $6.9 $53,530 - $69,690	-10,100 Reduced 5.88%	161,650 $857,000
Q1 2018 May 14, 2018	SELL	$3.65 - $7.95 $86,870 - $189,210	-23,800 Reduced 12.17%	171,750 $996,000
Q4 2017 Feb 09, 2018	SELL	$2.85 - $3.95 $94,620 - $131,140	-33,200 Reduced 14.51%	195,550 $684,000
Q3 2017 Nov 14, 2017	SELL	$2.45 - $3.65 $1,470 - $2,190	-600 Reduced 0.26%	228,750 $835,000
Q2 2017 Aug 14, 2017	BUY	N/A	229,350	229,350 $573,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.29 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$70,964
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,197
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $449M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account